DC vaccines combined with ICIs are also an effective treatment strategy, and preclinical studies had shown that DC vaccines combined with PD-1 inhibitors led to smaller tumor volume and better OS in the treatment of hepatocellular carcinoma (HCC) (145). This evidence concerns the gene PDCD1 and neoplasm.